| 产品描述: | MRTX-EX185 formic is a potent KRAS (G12D) inhibitor with an IC50 of 90 nM. MRTX-EX185 formic can binds both GDP-loaded and active GNP states of KRAS and KRAS (G12D). MRTX-EX185 formic exhibits broad-spectrum binding properties with IC50s of 110, 290, 130 and 240 nM for KRAS WT, KRAS (G12C), KRAS (Q61H), KRAS (G13D). MRTX-EX185 formic also binds GDP-loaded HRAS. MRTX-EX185 formic can be used to study various RAS-driven tumors (such as pancreatic cancer) . |
| 靶点: |
KRas G12D:90 nM (IC50);K-Ras WT:110 nM (IC50);KRas G12C:290 nM (IC50);KRas Q61H:130 nM (IC50);KRAS G13D:240 nM (IC50);KRas G12V:700 nM (IC50) |
| 体内研究: |
MRTX-EX185 (0.1 nM-100 μM) formic 可抑制 KRAS (G12D) 驱动的 SW-1990 胰腺癌细胞增殖 (IC50 = 70 nM),并且对非 KRAS 依赖性细胞系 (HEK293 细胞) 无毒性。 MRTX-EX185 (1 nM-100 μM) formic 可显著抑制 KRAS(G12C) 驱动的细胞谱系中的 ERK 磷酸化 (p-ERK)。 |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.638 ml |
8.188 ml |
16.375 ml |
| 5 mM |
0.328 ml |
1.638 ml |
3.275 ml |
| 10 mM |
0.164 ml |
0.819 ml |
1.638 ml |
| 50 mM |
0.033 ml |
0.164 ml |
0.328 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |